From my observation of the last 3-4 years
The CEO bought Revenue Increase.
Paying Teva Top $. Capital Raising and
Debt. This obviously increased Revenue.
So now Company has valuation $3billion+.
CEO now deserves huge Salary increases
and also his Senior Executives accordingly.
Since then for past 3 years Company has consistently failed to deliver. Shareholders
particularly LT ones remained loyal and have
paid the price. CEO and his Yes Men fellow
cohorts not suffered at all as far as I can see.
I wish to see some of the Pain Shared and
said CEO be financially rewarded relative to
current share price. Otherwise leave and allow
a Competant Individual to replace you.
New Product Approvals, page-225
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.93 |
Change
-0.170(2.39%) |
Mkt cap ! $589.5M | |||
| Open | High | Low | Value | Volume |
| $6.96 | $7.10 | $6.92 | $445.2K | 63.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 2808 | $6.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.96 | 1106 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$6.91 |
Change
-0.170 ( 2.37 %) |
||||
| Open | High | Low | Volume | ||
| $7.05 | $7.06 | $6.91 | 8328 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| MYX (ASX) Chart |